✦ LIBER ✦

Pharmacokinetics of four metabolites of DA-125, a new anthracycline antineoplastic agent after single and multiple intravenous administration to rats

✍ Scribed by S. D. Lee; W. I. Lee; H. J. Shim; E. D. Lee; W. B. Kim; J. Yang; C.-K. Kim; M. G. Lee

Book ID: 114738597
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 711 KB
Volume: 21
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.1996.tb01140.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHARMACOKINETICS OF DA-125, A NEW ANTHRA

PHARMACOKINETICS OF DA-125, A NEW ANTHRACYCLINE, AFTER INTRAVENOUS ADMINISTRATION TO URANYL NITRATE-INDUCED ACUTE RENAL FAILURE RATS OR PROTEIN--CALORIE MALNUTRITION RATS

✍ Yoon G. Kim; Eun J. Yoon; Woo H. Yoon; Hyun J. Shim; Sang D. Lee; Won B. Kim; Ju 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

The pharmacokinetics of DA-125 were compared after intravenous (i.v.) administration of the drug, 10 mg kg-I, to control male Sprague-Dawley rats ( n = 9) and uranyl nitrateinduced acute renal failure (U-ARF, n = 12) rats, or male SpragueDawley rats fed on a 23% (control, n = 8) or a 5% (protein-cal

Pharmacokinetics and antitumour activity

Pharmacokinetics and antitumour activity of a new anthracycline, DA-125, after intravenous administration to subcutaneously implanted Lewis-lung-carcinoma-bearing mice

✍ Sang D. Lee; Jeong B. Park; Woo I. Lee; Hyun J. Shim; Eung D. Lee; Jong J. Lee; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

The pharmacokinetics and tissue distribution of Ml-M4 were compared after intravenous administration of DA-125,25 mg kg-I, to BDF, mice (n = 5 at each sampling time) and subcutaneously implanted Lewis-lungcarcinoma-bearing BDF, mice (n = 10 at each sampling time). The mean plasma concentrations of M

Pharmacokinetics of DA-7218, a new oxazo

Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats

✍ Soo K. Bae; Si H. Yang; Karen N. Shin; Jae K. Rhee; Moohi Yoo; Myung G. Lee 📂 Article 📅 2007 🏛 Pharmaceutical Press 🌐 English ⚖ 539 KB

Pharmacokinetics of a new carbapenem, DA

Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus

✍ So H. Kim; Won B. Kim; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Because physiological changes occurring in diabetes patients could alter the pharmacokinetics of drugs used to treat the disease, the pharmacokinetics and tissue distribution of DA-1131, a new carbapenem antibiotic, were investigated after 1-min intravenous (iv) administration of the drug, 50 mg kg

Pharmacokinetics and tissue distribution

Pharmacokinetics and tissue distribution of a new carbapenem, DA-1131, after intravenous administration to mice, rats, rabbits and dogs

✍ So H. Kim; Jong W. Kwon; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

The pharmacokinetic parameters including tissue distribution and/or biliary excretion of DA-1131, a new carbapenem, were evaluated after intravenous (iv) administration to mice, rats, rabbits, and dogs. After i.v. administration to mice (20, 50, 100, and 200 mg kg-1), rats (50, 100, 200, and 500 mg

Pharmacokinetics of DA-8159, a new erect

Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: Hepatic and intestinal first-pass effects

✍ Hyun J. Shim; Yu C. Kim; Kyung J. Park; Dong S. Kim; Jong W. Kwon; Won B. Kim; M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

The purposes of this study were to report dose-independent (after intravenous administration) and dose-dependent (after oral administration) area under the curve of plasma concentration versus time from time zero to time infinity (AUC), and gastric, intestinal, and/or hepatic first-pass effects (aft